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The HIV epidemic has existed for more than three decades and the prevalence in sub-Saharan Africa is one of the highest in the world, accounting for ~70% of the global burden of disease. [1] The estimated overall HIV prevalence rate is ~11% of the total South African (SA) population. KwaZulu-Natal (KZN) Province in SA is at the epicentre of this pandemic. [2, 3] About 25% of the province's adult population live with the virus, compared with a national average of 18%. [4] In KZN, there are districts with higher rates of infection, e.g. Amajuba district, where 47% of women attending antenatal clinics tested positive, while 51% of women aged 25 -29 years who participated in a household survey in the rural district of Umkhanyakude were found to be HIVpositive. [5] Surveys in Eshowe and Mbongolwane districts, conducted by Médecins Sans Frontières (MSF), reported that women were the most affected by the disease, with 56% aged between 30 and 39 years currently living with HIV. [6] The introduction of highly active antiretroviral treatment (HAART) has extended the life expectancy of individuals who are HIV-infected, effectively changing infection with this retrovirus from a lethal condition to a manageable chronic disease. Increasing numbers of HIV-infected patients, therefore, present with medical and surgical conditions similar to those seen in HIV-negative patients. Recent studies have shown that irrespective of the use of HAART, sepsis among HIV-infected patients is increasing, while the incidence of acute respiratory insufficiency and Pneumocystisrelated pneumonia is decreasing. [7] [8] [9] In HIV-infected patients, sepsis accounted for 12 -31% of HIV-positive patients' admission to intensive care units (ICUs), and was associated with a worse prognosis. [7] [8] [9] [10] Despite the significant prevalence of the disease in KZN, the impact of HIV co-infection on the clinical outcome of surgical patients in our setting remains largely unknown. Over a decade ago, and prior to the national roll-out of the HAART programme, a study by Cacala et al. [2] showed that HIV status does not influence the clinical outcome in general surgical patients. Their study included trauma and non-trauma patients, and did not focus solely on the outcome of HIV-infected patients with surgical sepsis. Since the national HAART programme, there has been no subsequent documentation in the literature on the outcome of HIV infection in surgical patients. More specifically, there has not been any documentation on the outcome of surgical sepsis in HIV-infected patients in KZN.
Surgical sepsis is a broad term that covers a spectrum of conditions where patients have a septic process that requires surgical source control. The current understanding of the impact of sepsis on HIVinfected patients is limited, even though, despite the significant increase in survival and quality of life, HIV/AIDS patients have been systematically excluded from sepsis studies. [7] The study objective was to review and quantify the differences in clinical course and outcome between HIV-positive and HIV-negative patients with primary surgical sepsis in a major university hospital in SA. RESEARCH hospitals, Pietermaritzburg, SA. Our regional electronic registry was reviewed -from January 2010 to December 2014. KZN is located along the east coast of the country, with a population of >11 million; 50% of the population live in rural areas. The PMSS provides definitive surgical care to the city of Pietermaritzburg, the capital of KZN Province. It also serves as the referral centre for 19 other rural hospitals in the province, with a total catchment population of >3 million. [11] The study All adult emergency general surgical patients (>15 years of age), who were admitted by the PMSS, were reviewed. All patients fulfilling the American College of Chest Physicians/Society of Critical Care Medicine Consensus criteria for sepsis, severe sepsis or septic shock, [12] and with a documented surgical source of infection, were reviewed. According to these criteria, sepsis is defined as a complex systemic inflammatory response syndrome (SIRS) to infection; severe sepsis is defined as a systemic inflammatory syndrome in response to infection that is associated with acute organ dysfunction; and septic shock is defined as sepsis with refractory hypotension (systolic blood pressure <90 mmHg or mean arterial pressure <70 mmHg, despite resuscitation with 30 mL/kg of crystalloid). SIRS comprises two or more of the following:
Methods

Clinical setting
• temperature >38°C or <36°C • pulse >90 beats/minute • respiratory rate >20 breaths/minute or PaCO 2 <32 mmHg • white cell count >12 ×10 9 /L or >10% immature band forms.
Only surgical patients with a hospital record with laboratory documentation of HIV status were included. As this was a retrospective study based on a prospectively maintained database, no patients were tested as a part of the study. Routine clinical care information was obtained from the database and patients' medical records.
All patients with incomplete records or without a proven surgical source of sepsis were excluded. Data from the registry included basic demographic information, admission physiological parameters, and diagnosis. Clinical outcomes were described in terms of the need for ICU admission, length of hospital stay, morbidity and mortality. Complications during hospitalisation and not related to the primary reason for surgical treatment, were further grouped by organ systems (e.g. hospital-acquired pneumonia was classified as respiratory complications, acute kidney injury as renal complications, and surgical site infection as wound complications). The surgical pathologies were classified into the following categories: intra-abdominal sepsis, limb sepsis, and soft-tissue sepsis. All patients who were proven to be HIV-positive were compared with those who were known to be HIV-negative. Further subgroup comparisons were made in HIV-positive patients based on their CD4 counts (CD4 <200 cells/μL or >200 cells/μL). A CD 4 count <200 cells/μL corresponds to stage III disease; a count greater than this is stage II or I disease.
Statistical analysis
Data were processed and analysed using Stata 13.0 (StataCorp., USA). Continuous variables were summarised using means and standard deviations (SDs). If there was evidence of skewing/asymmetrical outliers, the median and interquartile range (IQR) were presented instead. Categorical variables were summarised using frequencies and percentages. 
Results
Demographic characteristics
During the 5-year study period, 675 patients with a documented surgical source of sepsis were reviewed. Of these, 332 (49%) were male and the mean age was 46 (SD 19) years. Of the cohort of 675 patients, the HIV status was known in 237 (35%). Of these, 146 (62%) were HIV-positive and 91 (38%) were HIV-negative. The status of the remaining 438 was unknown and was not considered further. The demographics of the HIV-positive and HIV-negative group are given in Table 1 . There were significantly more female and rural patients, as well as concomitant tuberculosis (TB) among HIV-positive patients compared with those who were HIV-negative.
Clinical presentation and disease spectrum
The clinical characteristics of the patients are summarised in Table 2 . The disease spectrum for both groups is given in Table 3 . TB of the abdomen was significantly more common in HIV-positive than HIVnegative patients (10% v. 2%, p=0.033). Of the total 237 patients, 194 (82%) required operative procedures for source control ( HIV-positive v. HIV-negative patients (78% (114/147) v. 88% (80/91), p=0.045). Table 4 summarises operative interventions for source control in both groups. Table 5 compares the number of patients with morbidities (by organ system) and the length of hospital stay between HIV-positive and HIV-negative patients. Some patients had more than one organ system complication, while others had no complications. There were no significant differences in overall morbidity or mortality between these patients.
Clinical outcomes
Mortality by CD4 count
Among the HIV-positive patients with a CD4 count <200 cells/µL or stage III disease, mortality was 60% (15/25), while that in patients with HIV and a CD4 count >200 cells/µL (stage II and stage I disease) was 2% (2/101). This was highly statistically significant (p<0.001).
Discussion
The high prevalence of HIV in KZN results in a significant number of patients presenting with an acute surgical illness together with 
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HIV co-infection. [1] [2] [3] Patients may present with a complication due to their chronic immunosuppressed state or with an unrelated surgical illness. Immunosuppression results in opportunistic infections such as TB and a number of viral infections. In our study, very few patients presented with specific surgical complications of HIV -the most common HIV-associated cause of surgical sepsis was abdominal TB.
Other than TB of the abdomen being significantly more common in HIV-positive patients, there was no difference in the spectrum of disease. There were no complications of visceral vasculopathy, HIV-related cholangiopathy or colitis. This is consistent with the literature, indicating that TB is the overwhelming opportunistic infection associated with HIV disease in Africa. [13] [14] [15] Our study showed no significant differences in overall morbidity or mortality between HIVinfected and HIV-uninfected patients. This is in contrast to the documented poorer outcome of sepsis in HIV-infected patients. [7] [8] [9] [10] In these studies, no differentiation is made between patients with surgical sepsis and those without.
Sixty-two percent of our study patients with known results were HIV-positive, which is higher than the reported average prevalence (25.2%) of HIV in KZN. [4] This might be due to our study having significantly more females and more rural patients, and may reflect documented regional differences in the prevalence of HIV infection. [5, 6] The management of patients with a surgical disease and HIV co-infection remains controversial. Many have suggested that HIV co-infection places surgical patients at risk of major morbidity and have advocated a minimalistic and ultimately fatalistic approach to patients with acute surgical emergencies. This view was first challenged by Bhag wan jee et al. [3] at King Edward VIII Hospital in Durban. In his controversial prospective trial, it was shown that HIV co-infection appeared to offer a protective advantage to patients admitted to the surgical ICU. It was postulated that the immunosuppression inherent in HIV infection dampened down the septic response to critical illness. A decade later, Cacala et al., [2] from Prince Mshiyeni Memorial Hospital in Durban, showed that HIV status does not influence the outcome of general surgical admissions and should not influence surgical management decisions. These authors reported that in their heterogeneous population of HIV-positive surgical patients, CD4 counts were unrelated to outcome. Both these studies were from the era prior to the roll-out of the national HAART programme. In general, CD4 count is regarded as being a proxy 
marker for immune function. In our study, a significant difference in outcome was noted between HIV patients with a CD4 count <200 cells/µL and those with CD4 counts >200 cells/µL. HIV-infected individuals with surgical sepsis and a CD4 count ˂200 cells/ µL are 36 times more likely to die than HIVinfected patients who have a CD4 count >200 cells/µL. These findings differ from those of Caca la et al. [2] Our findings were consistent with those in the litera ture. [16, 17] Feng et al. [18] used logistic regression to determine risk factors for the development of sepsis in surgical patients with HIV-infection, with and without sepsis. They reported that in HIV-infected patients who required surgery for malignancy or sepsis, those with a low CD4 count and with hypoalbuminaemia before surgery, had a higher probability of developing postoperative sepsis. Further studies are required to define the impact of CD4 counts on other aspects of clinical outcome in surgical patients with sepsis.
Conclusion
The clinical presentation and spectrum of surgical sepsis disease in patents with HIV coinfection were not markedly different to those in patients who are not infected with HIV. In patients with a CD4 count ˂200 cells/µL, the mortality was significantly higher.
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